Login

Ask AI

$BCDA

$0.90 -$0.02 (2.33%) After hours

$BCDA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

Management Team

From the proxy statement filed Nov 3, 2025

Officer	Age	In this role	Joined	2024 pay	Source
Peter Altman President, Chief Executive Officer, and Director	59	Not stated	Not stated	$493,388
David McClung Chief Financial Officer	62	Since 2017 9 years	2013	$354,942
Edward Gillis Senior Vice President of Devices	63	Since 2020 6 years	Not stated	$251,804

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Nov 3, 2025

Directors

6

serving now

Independent

0 of 1

stated in the proxy; 5 not stated

Average tenure

Not stated

from year joined

CEO also chairs the board

Not stated

no chair stated

Director	Age	On board	Independent	Committees	Other public boards	2024 pay	Source
Altman	Not stated	Not stated	Not independent	None stated	None stated	Not stated
Jay Moyes	Not stated	Not stated	Not stated	Audit Committee · Chair	None stated	$62,966
Richard Krasno, Ph.D.	Not stated	Not stated	Not stated	None stated	None stated	$55,466
Bill Facteau	Not stated	Not stated	Not stated	None stated	None stated	$49,466
Andrew Blank	Not stated	Not stated	Not stated	Compensation Committee · Chair Nominating and Corporate Governance Committee · Chair	None stated	$95,466
Jim Allen	Not stated	Not stated	Not stated	None stated	None stated	$46,966

Nominated to join at the meeting

Not on the board yet; they join only if elected.

Marvin Slosman

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

23 disclosed in the proxy filed Nov 3, 2025

BSLF, L.L.C.

an entity owned and controlled by Andrew Blank, a member of our board of directors

$112,876

2024

Company remitted litigation service credits to BSLF under the settlement of the Litigation Funding Agreement

With the Company Open in proxy

Peter Altman

President, Chief Executive Officer, and a member of our board of directors

$50,000

February 2024

Purchased common stock and warrants in the February 2024 private placement

With the Company Open in proxy

Thomas A. Satterfield, Jr.

a holder of 5% stockholder

$210,000

August 2024

Entities affiliated with him invested in the August 2024 registered offering

With the Company Open in proxy

Andrew Blank

a member of our board of directors

$333,000

August 2024

Invested in the August 2024 registered offering

With the Company Open in proxy

Jim Allen

a member of our board of directors

$150,000

August 2024

Invested in the August 2024 registered offering

With the Company Open in proxy

Peter Altman

President, Chief Executive Officer, and a member of our board of directors

$125,000

August 2024

Invested in the August 2024 registered offering

With the Company Open in proxy

David McClung

Chief Financial Officer

$25,000

August 2024

Invested in the August 2024 registered offering

With the Company Open in proxy

Thomas A. Satterfield, Jr.

a holder of 5% stockholder

$150,000

April 2025

Entities affiliated with him invested in the April 2025 private placement

With the Company Open in proxy

Andrew Blank

a member of our board of directors

$250,000

April 2025

Invested in the April 2025 private placement

With the Company Open in proxy

Simon H. Stertzer, M.D.

a member of our board of directors

$200,000

April 2025

Invested in the April 2025 private placement

With the Company Open in proxy

Richard Krasno, Ph.D.

a member of our board of directors

$25,000

April 2025

Invested in the April 2025 private placement

With the Company Open in proxy

Bill Facteau

a member of our board of directors

$25,000

April 2025

Invested in the April 2025 private placement

With the Company Open in proxy

Peter Altman

President, Chief Executive Officer, and a member of our board of directors

$50,000

April 2025

Invested in the April 2025 private placement

With the Company Open in proxy

David McClung

Chief Financial Officer

$25,000

April 2025

Invested in the April 2025 private placement

With the Company Open in proxy

Thomas A. Satterfield, Jr.

a holder of 5% stockholder

$100,000

June 2025

Entities affiliated with him invested in the June 2025 private placement

With the Company Open in proxy

Andrew Blank

a member of our board of directors

$150,000

June 2025

Invested in the June 2025 private placement

With the Company Open in proxy

Simon H. Stertzer, M.D.

a member of our board of directors

$150,000

June 2025

Invested in the June 2025 private placement

With the Company Open in proxy

Peter Altman

President, Chief Executive Officer, and a member of our board of directors

$50,000

June 2025

Invested in the June 2025 private placement

With the Company Open in proxy

David McClung

Chief Financial Officer

$10,000

June 2025

Invested in the June 2025 private placement

With the Company Open in proxy

Thomas A. Satterfield, Jr.

a holder of 5% stockholder

$500,000

September 2025

Entities affiliated with him invested in the September 2025 offering

With the Company Open in proxy

Andrew Blank

a member of our board of directors

$360,000

September 2025

Invested in the September 2025 offering

With the Company Open in proxy

Simon H. Stertzer, M.D.

a member of our board of directors

$498,000

September 2025

Invested in the September 2025 offering

With the Company Open in proxy

Peter Altman

President, Chief Executive Officer, and a member of our board of directors

$60,000

September 2025

Invested in the September 2025 offering

With the Company Open in proxy

Loading...

Comments